Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhimin Shao

Showing results (131-140 of 203) with videos related to

Pageof 21
Sort By:
Investigational New Drugs|February 10, 2020
Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomiting following highly emetogenic chemotherapy: an open label, randomized, multicenter phase III trialJun Cao, Quchang Ouyang, Shusen Wang, et al.
Japanese Journal of Clinical Oncology|February 23, 2021
Pertuzumab and trastuzumab as adjuvant treatment for HER2-positive early breast cancer: outcomes in Chinese patients in the APHINITY studyZhimin Shao, Ling-Ming Tseng, Chiun-Sheng Huang, et al.
Cancer Letters|January 12, 2011
Estrogen receptor-related genes as an important panel of predictors for breast cancer response to neoadjuvant chemotherapyYizuo Chen, Canming Chen, Benlong Yang, et al.
Oncotarget|July 1, 2016
Fulvestrant 500 mg vs 250 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer: a randomized, double-blind registrational trial in ChinaQingyuan Zhang, Zhimin Shao, Kunwei Shen, et al.
Cancer Biology & Medicine|August 19, 2025
Feasibility of sentinel lymph node biopsy omission after integration of <sup>18</sup>F-FDG dedicated lymph node PET in early breast cancer: a prospective phase II trialJunjie Li, Jingyi Cheng, Guangyu Liu, et al.
Biomarker Research|January 7, 2024
Long-read transcriptome landscapes of primary and metastatic liver cancers at transcript resolutionZhiao Chen, Qili Shi, Yiming Zhao, et al.
Cancer Cell International|August 14, 2019
LINC00309 is associated with short disease-free survival in breast cancerSheng Huang, Yayun Chi, Weiru Chi, et al.
Frontiers in Oncology|November 16, 2020
A Short-Term Effect of Wearable Technology-Based Lifestyle Intervention on Body Composition in Stage I-III Postoperative Breast Cancer SurvivorsChangming Zhou, Miao Mo, Zezhou Wang, et al.
Journal of Oncology|February 27, 2023
The Role of Radiotherapy for Patients with Unresectable Locally Advanced Breast Cancer following Neoadjuvant Systemic TherapyXiaofang Wang, Jin Meng, Xiaomeng Zhang, et al.
Breast Cancer (Tokyo, Japan)|November 8, 2019
Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world settingXuanyi Wang, Jurui Luo, Kairui Jin, et al.
Pageof 21

Showing results (131-140 of 203) with videos related to

Sort By:
Pageof 21
Investigational New Drugs|February 10, 2020
Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomiting following highly emetogenic chemotherapy: an open label, randomized, multicenter phase III trialJun Cao, Quchang Ouyang, Shusen Wang, et al.
Japanese Journal of Clinical Oncology|February 23, 2021
Pertuzumab and trastuzumab as adjuvant treatment for HER2-positive early breast cancer: outcomes in Chinese patients in the APHINITY studyZhimin Shao, Ling-Ming Tseng, Chiun-Sheng Huang, et al.
Cancer Letters|January 12, 2011
Estrogen receptor-related genes as an important panel of predictors for breast cancer response to neoadjuvant chemotherapyYizuo Chen, Canming Chen, Benlong Yang, et al.
Oncotarget|July 1, 2016
Fulvestrant 500 mg vs 250 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer: a randomized, double-blind registrational trial in ChinaQingyuan Zhang, Zhimin Shao, Kunwei Shen, et al.
Cancer Biology & Medicine|August 19, 2025
Feasibility of sentinel lymph node biopsy omission after integration of <sup>18</sup>F-FDG dedicated lymph node PET in early breast cancer: a prospective phase II trialJunjie Li, Jingyi Cheng, Guangyu Liu, et al.
Biomarker Research|January 7, 2024
Long-read transcriptome landscapes of primary and metastatic liver cancers at transcript resolutionZhiao Chen, Qili Shi, Yiming Zhao, et al.
Cancer Cell International|August 14, 2019
LINC00309 is associated with short disease-free survival in breast cancerSheng Huang, Yayun Chi, Weiru Chi, et al.
Frontiers in Oncology|November 16, 2020
A Short-Term Effect of Wearable Technology-Based Lifestyle Intervention on Body Composition in Stage I-III Postoperative Breast Cancer SurvivorsChangming Zhou, Miao Mo, Zezhou Wang, et al.
Journal of Oncology|February 27, 2023
The Role of Radiotherapy for Patients with Unresectable Locally Advanced Breast Cancer following Neoadjuvant Systemic TherapyXiaofang Wang, Jin Meng, Xiaomeng Zhang, et al.
Breast Cancer (Tokyo, Japan)|November 8, 2019
Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world settingXuanyi Wang, Jurui Luo, Kairui Jin, et al.
Pageof 21